Short answer
BrightSpring Health Services, Inc. (BTSG) filed its Q2 2026 10-Q quarterly report on Jul 31, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $3.9B (up 23.0% year over year) with net income of $84M.
Q2 2026 key financials · XBRL
- Revenue
- $3.9B
- +23.0% YoY · +7.2% QoQ
- Net income
- $84M
- +198.8% YoY · −43.3% QoQ
- Operating margin
- 3.4%
- Gross margin
- 12.7%
- EPS (diluted)
- $0.38
- +192.3% YoY · −43.3% QoQ
Source: XBRL data from the BrightSpring Health Services, Inc. (BTSG) Q2 2026 10-Q on SEC EDGAR. USD.
BrightSpring Health Services, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No Risk Factors section provided in the supplied excerpt
- New debt amendment: Amendment No. 10 to First Lien Credit Agreement dated May 28, 2026
- Insider trading: PharMerica president’s plan covers up to 11,973 shares beginning September 14, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other BrightSpring Health Services, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.